Xtoro Approval History
Marketing Status: Discontinued
Xtoro (finafloxacin otic suspension) is a fluoroquinolone antimicrobial for the treatment of acute otitis externa, commonly known as swimmer’s ear.
Development History and FDA Approval Process for Xtoro
|Dec 17, 2014||FDA Approves Xtoro (finafloxacin) Otic Suspension to Treat Swimmer’s Ear|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.